SoluBest was founded in 2001 to develop an easy-to-integrate technological platform for solving one of the most pressing issues facing the pharma industry: the problem of drug insolubility.
Privately owned and funded, SoluBest has recently concluded its 4th round of financing.
SoluBest is pursuing a licensing based business model whereby client molecules are formulated in exchange for milestones and royalties.
In tandem, the company is actively pursuing its a pipeline of its own, using its platform to reformulate insoluble, marketed drugs.